Finch Therapeutics Group, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Finch Therapeutics Group, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2020 to Q2 2024.
  • Finch Therapeutics Group, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 1.61M shares, a 0.06% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 1.61M +1K +0.06% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 1.61M -46.5M -96.7% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 1.61M +4.05K +0.25% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 1.61M -46.2M -96.6% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 1.6M -46.1M -96.6% Jun 30, 2023 10-Q/A 2023-08-11
Q1 2023 48.1M +612K +1.29% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 1.6M -45.9M -96.6% Dec 31, 2022 10-K 2024-03-25
Q3 2022 47.8M +372K +0.78% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 47.7M +260K +0.55% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 47.5M +305K +0.65% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 47.5M +39.1M +466% Dec 31, 2021 10-K 2023-03-23
Q3 2021 47.5M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 47.4M Jun 30, 2021 10-Q 2021-08-10
Q1 2021 47.2M Mar 31, 2021 10-Q 2021-05-13
Q4 2020 8.39M Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.